Report from the second MIB (Melanoma Independent Board) Conference, 27–28 October 2014

The second Melanoma Independent Board (MIB) meeting was held in Rome, Italy from 27–28 October 2014. The themes of this meeting were once again innovation and sustainability and it brought together health providers, researchers, government representatives, journalists, patients, and pharmaceutical r...

Descripción completa

Detalles Bibliográficos
Autores principales: Testori, Alessandro, Rossi, Carlo Riccardo, Ascierto, Paolo, de Lorenzo, Francesco, Mozzillo, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2015
Materias:
Conference Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335967/
https://www.ncbi.nlm.nih.gov/pubmed/25729424
http://dx.doi.org/10.3332/ecancer.2015.511
_version_ 1782358411478827008
author Testori, Alessandro
Rossi, Carlo Riccardo
Ascierto, Paolo
de Lorenzo, Francesco
Mozzillo, Nicola
author_facet Testori, Alessandro
Rossi, Carlo Riccardo
Ascierto, Paolo
de Lorenzo, Francesco
Mozzillo, Nicola
author_sort Testori, Alessandro
collection PubMed
description The second Melanoma Independent Board (MIB) meeting was held in Rome, Italy from 27–28 October 2014. The themes of this meeting were once again innovation and sustainability and it brought together health providers, researchers, government representatives, journalists, patients, and pharmaceutical representatives.
format Online
Article
Text
id pubmed-4335967
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Cancer Intelligence
record_format MEDLINE/PubMed
spelling pubmed-43359672015-02-27 Report from the second MIB (Melanoma Independent Board) Conference, 27–28 October 2014 Testori, Alessandro Rossi, Carlo Riccardo Ascierto, Paolo de Lorenzo, Francesco Mozzillo, Nicola Ecancermedicalscience Conference Report The second Melanoma Independent Board (MIB) meeting was held in Rome, Italy from 27–28 October 2014. The themes of this meeting were once again innovation and sustainability and it brought together health providers, researchers, government representatives, journalists, patients, and pharmaceutical representatives. Cancer Intelligence 2015-02-19 /pmc/articles/PMC4335967/ /pubmed/25729424 http://dx.doi.org/10.3332/ecancer.2015.511 Text en © the authors; licensee ecancermedicalscience. http://creativecommons.org/licenses/by/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Conference Report
Testori, Alessandro
Rossi, Carlo Riccardo
Ascierto, Paolo
de Lorenzo, Francesco
Mozzillo, Nicola
Report from the second MIB (Melanoma Independent Board) Conference, 27–28 October 2014
title Report from the second MIB (Melanoma Independent Board) Conference, 27–28 October 2014
title_full Report from the second MIB (Melanoma Independent Board) Conference, 27–28 October 2014
title_fullStr Report from the second MIB (Melanoma Independent Board) Conference, 27–28 October 2014
title_full_unstemmed Report from the second MIB (Melanoma Independent Board) Conference, 27–28 October 2014
title_short Report from the second MIB (Melanoma Independent Board) Conference, 27–28 October 2014
title_sort report from the second mib (melanoma independent board) conference, 27–28 october 2014
topic Conference Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335967/
https://www.ncbi.nlm.nih.gov/pubmed/25729424
http://dx.doi.org/10.3332/ecancer.2015.511
work_keys_str_mv AT testorialessandro reportfromthesecondmibmelanomaindependentboardconference2728october2014
AT rossicarloriccardo reportfromthesecondmibmelanomaindependentboardconference2728october2014
AT asciertopaolo reportfromthesecondmibmelanomaindependentboardconference2728october2014
AT delorenzofrancesco reportfromthesecondmibmelanomaindependentboardconference2728october2014
AT mozzillonicola reportfromthesecondmibmelanomaindependentboardconference2728october2014

Ejemplares similares